1. Home
  2. ALKS vs CAVA Comparison

ALKS vs CAVA Comparison

Compare ALKS & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$45.24

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$53.83

Market Cap

6.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALKS
CAVA
Founded
1987
2006
Country
Ireland
United States
Employees
2050
12900
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.1B
IPO Year
2012
2023

Fundamental Metrics

Financial Performance
Metric
ALKS
CAVA
Price
$45.24
$53.83
Analyst Decision
Buy
Buy
Analyst Count
20
28
Target Price
$56.21
★ $81.83
AVG Volume (30 Days)
1.9M
★ 2.6M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.39
Revenue
★ $1,475,899,000.00
$1,179,664,000.00
Revenue This Year
$23.57
$27.36
Revenue Next Year
$6.58
$20.82
P/E Ratio
★ N/A
$132.83
Revenue Growth
N/A
★ 22.41
52 Week Low
$27.00
$43.41
52 Week High
$55.67
$98.79

Technical Indicators

Market Signals
Indicator
ALKS
CAVA
Relative Strength Index (RSI) 59.90 50.69
Support Level $39.41 $50.17
Resistance Level $45.20 $55.31
Average True Range (ATR) 1.39 2.44
MACD 0.62 0.13
Stochastic Oscillator 96.63 56.77

Price Performance

Historical Comparison
ALKS
CAVA

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About CAVA CAVA Group Inc.

Cava is an emerging fast-casual restaurant chain with $1.2 billion in sales across 439 US company-owned units in 2025. The firm derives most of its revenue from the sale of Mediterranean- and Greek-inspired customizable bowls, salads, pita wraps, and beverages, using an assembly-line format. Cava centrally prepares and manufactures the sauces and dips served in its restaurants and sold in grocery stores. All of Cava's revenue is in the US, with the majority of its footprint in the Southeast and Southwest.

Share on Social Networks: